Skip to main content
Livermore
Livermore
ZHEN

Cornerstone Advisors, LLC

SEC CIK
0001775446
Latest filing
Aug 7, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Cornerstone Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
24,760
Value
$12.3M
% of portfolio
0.4%
Quarters held
21
Since Q1 2021
Holdings of VRTX by Cornerstone Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202624,760$12.3M0.4%+24,760NewHolders
Q1 20260$00.0%−10,700−100.0%Sold outHolders
Q4 202510,700$4.85M0.2%−25,400−70.4%ReducedHolders
Q3 202536,100$14.1M0.5%−500−1.4%ReducedHolders
Q2 202536,600$16.3M0.6%+23,600+181.5%AddedHolders
Q1 202513,000$6.30M0.3%00.0%UnchangedHolders
Q4 202413,000$5.24M0.2%00.0%UnchangedHolders
Q3 202413,000$6.05M0.2%+800+6.6%AddedHolders
Q2 202412,200$5.72M0.2%−100−0.8%ReducedHolders
Q1 202412,300$5.14M0.2%00.0%UnchangedHolders
Q4 202312,300$5.00M0.2%−4,800−28.1%ReducedHolders
Q3 202317,100$5.95M0.3%−6,200−26.6%ReducedHolders
Q2 202323,300$8.20M0.4%+3,300+16.5%AddedHolders
Q1 202320,000$6.30M0.3%00.0%UnchangedHolders
Q4 202220,000$5.78M0.3%−7,000−25.9%ReducedHolders
Q3 202227,000$7.82M0.4%00.0%UnchangedHolders
Q2 202227,000$7.61M0.4%+5,000+22.7%AddedHolders
Q1 202222,000$5.74M0.3%00.0%UnchangedHolders
Q4 202122,000$4.83M0.3%00.0%UnchangedHolders
Q3 202122,000$3.99M0.2%00.0%UnchangedHolders
Q2 202122,000$4.44M0.3%+9,000+69.2%AddedHolders
Q1 202113,000$2.79M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.